Skip to main content
. 2010 Sep 7;50(1):137–145. doi: 10.1093/rheumatology/keq261

Table 2.

Demographics of patients in the registry (analysis of 275 patients)a

Diagnosis n (%)
Definite JDM 203 (73.8)
Probable JDM 48 (17.5)
Definite JPM 4 (1.5)
Probable JPM 3 (1.1)
Other IIMsb 4 (1.5)
Focal myositis 5 (1.8)
MCTD 8 (2.9)
Demographic data, n (%) In cases of definite or probable JDM or JPM (n = 258)
Sex
    Girls 182 (70.5)
    Boys 76 (29.5)
Ethnicity
    White 207 (80.2)
    Black—Caribbean 9 (3.5)
    Black—African 7 (2.7)
    Black—Other 4 (1.6)
    Indian 6 (2.3)
    Pakistani 10 (3.9)
    Bangladeshi 1 (0.4)
    Chinese 0
    Other ethnicity 14 (5.4)
Baseline characteristics, cases of definite or probable JDM or JPM
Age at onset, median (IQR), years 6.3 (3.8–9.6)
Time between symptom onset and diagnosis, median (IQR), months 4 (2–10)
Physician’s global assessment at the time of diagnosis, median (IQR)c 4.8 (2.4–7.0)
CHAQ at the time of diagnosis, median (IQR)c 1.375 (0.625–2.375)
CMAS at time of diagnosis, median (IQR)c 31 (17–47)

aMedian length of completed follow-up data = 3.0 years, IQR = 1.1–5.0 years. bThese four cases were: two brothers with neonatal-onset multi-system inflammatory disorder that included prominent inflammatory myositis, one post-streptococcal myositis and one viral myositis. cFor those recruited prospectively where baseline measure at the time of diagnosis is available. IQR: interquartile range.